CanSino Biologics Inc.
Status: Publicly traded
Direct answer
CanSino Biologics Inc. is publicly traded on SHH under the ticker 688185.SS.
CanSino Biologics Inc. is a company dedicated to the development, manufacturing, and commercialization of vaccines across the People's Republic of China. Its current offerings encompass vaccines for recombinant novel coronavirus disease, specifically Convidecia and the Ad5-nCoV for inhalation, along with Ad5-EBOV, an Ebola virus vaccine. The company also provides MCV2 and MCV4, which are designed to prevent N....
Can you invest in CanSino Biologics Inc.?
Yes. CanSino Biologics Inc. trades publicly on SHH as 688185.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CanSino Biologics Inc.
Detailed equity research is provided by MarketSnap.